Protective associations of HDL with blood-brain barrier injury in multiple sclerosis patients
- PMID: 26243484
- PMCID: PMC4583090
- DOI: 10.1194/jlr.M060970
Protective associations of HDL with blood-brain barrier injury in multiple sclerosis patients
Abstract
The purpose of this work was to investigate the associations of serum cholesterol and apolipoproteins with measures of blood-brain barrier (BBB) permeability and CNS inflammation following the first clinical demyelinating event. This study included 154 patients [67% female; age, 29.5 ± 8.2 years (mean ± SD)] enrolled in a multi-center study of interferon β1-a treatment following the first demyelinating event. Blood and cerebrospinal fluid (CSF) were obtained at screening prior to treatment. A comprehensive serum lipid profile and multiple surrogate markers of BBB breakdown and CNS immune activity were obtained. Higher levels of serum HDL cholesterol (HDL-C) and ApoA-I were associated with lower CSF total protein level, CSF albumin level, albumin quotient, and CSF IgG level (all P ≤ 0.001 for HDL-C and all P < 0.01 for ApoA-I). HDL-C was also associated with CSF CD80+ (P < 0.001) and with CSF CD80+CD19+ (P = 0.007) cell frequencies. Higher serum HDL is associated with lower levels of BBB injury and decreased CD80+ and CD80+CD19+ cell extravasation into the CSF. HDL may potentially inhibit the initiation and/or maintenance of pathogenic BBB injury following the first demyelinating event.
Keywords: apolipoproteins; cholesterol; clinically isolated syndrome; high density lipoprotein.
Copyright © 2015 by the American Society for Biochemistry and Molecular Biology, Inc.
Figures
References
-
- Minagar A., Alexander J. S. 2003. Blood-brain barrier disruption in multiple sclerosis. Mult. Scler. 9: 540–549. - PubMed
-
- Ortiz G. G., Pacheco-Moises F. P., Macias-Islas M. A., Flores-Alvarado L. J., Mireles-Ramirez M. A., Gonzalez-Renovato E. D., Hernandez-Navarro V. E., Sanchez-Lopez A. L., Alatorre-Jimenez M. A. 2014. Role of the blood-brain barrier in multiple sclerosis. Arch. Med. Res. 45: 687–697. - PubMed
-
- Werring D. J., Brassat D., Droogan A. G., Clark C. A., Symms M. R., Barker G. J., MacManus D. G., Thompson A. J., Miller D. H. 2000. The pathogenesis of lesions and normal-appearing white matter changes in multiple sclerosis: a serial diffusion MRI study. Brain. 123: 1667–1676. - PubMed
-
- Holmøy T. 2009. The discovery of oligoclonal bands: a 50-year anniversary. Eur. Neurol. 62: 311–315. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
